Zobrazeno 1 - 10
of 175
pro vyhledávání: '"A. Schiviz"'
Autor:
Plaimauer, B., Schiviz, A., Kaufmann, S., Höllriegl, W., Rottensteiner, H. *, Scheiflinger, F.
Publikováno v:
In Journal of Thrombosis and Haemostasis November 2015 13(11):2053-2062
Autor:
Lewis, Kevin M., Schiviz, Alexandra, Hedrich, Hans-Christian, Regenbogen, Johannes, Goppelt, Andreas
Publikováno v:
In International Journal of Surgery September 2014 12(9):940-944
Autor:
De Meyer, Simon F., Savchenko, Alexander S., Haas, Michael S., Schatzberg, Daphne, Carroll, Michael C., Schiviz, Alexandra, Dietrich, Barbara, Rottensteiner, Hanspeter, Scheiflinger, Friedrich, Wagner, Denisa D. *
Publikováno v:
In Blood 20 December 2012 120(26):5217-5223
Autor:
Schiviz, Alexandra, Wuersch, Kuno, Piskernik, Christina, Dietrich, Barbara, Hoellriegl, Werner, Rottensteiner, Hanspeter, Scheiflinger, Friedrich, Schwarz, Hans Peter, Muchitsch, Eva-Maria
Publikováno v:
In Blood 21 June 2012 119(25):6128-6135
Autor:
Lillicrap, D.1, Schiviz, A.2, Apostol, C.2, Wojciechowski, P.3, Horling, F.2, Lai, C. K.3, Piskernik, C.2, Hoellriegl, W.2, Lollar, P.4
Publikováno v:
Haemophilia. Mar2016, Vol. 22 Issue 2, p308-317. 10p. 1 Color Photograph, 1 Diagram, 4 Charts, 2 Graphs.
Autor:
Alexandra Schiviz, Barbara Plaimauer, W. Höllriegl, F. Scheiflinger, Hanspeter Rottensteiner, Stefan Kaufmann
Publikováno v:
Journal of Thrombosis and Haemostasis. 13:2053-2062
SummaryBackground Acquired thrombotic thrombocytopenic purpura (TTP) is caused by an autoantibody-mediated deficiency of the von Willebrand factor-cleaving protease ADAMTS-13. Acute episodes of the disease are treated with a combination of immunosupp
Autor:
Hanspeter Rottensteiner, Alexandra Schiviz, Simon F. De Meyer, Claudia Tersteeg, Barbara Plaimauer, Friedrich Scheiflinger, Karen Vanhoorelbeke
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 35:2336-2342
Objective— The metalloprotease ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13) regulates the size of von Willebrand factor multimers. A deficiency in ADAMTS13 activity is associated with the life-threate
Autor:
A. Schiviz, F. Horling, Pete Lollar, W. Hoellriegl, P. Wojciechowski, C. K. Lai, C. Apostol, C. Piskernik, David Lillicrap
Publikováno v:
Haemophilia. 22:308-317
Introduction Acquired haemophilia A (AHA) is a rare, often severe, auto-immune bleeding disorder caused by the development of inhibitory antibodies (inhibitors) to factor VIII (FVIII). Bypassing agents, recombinant activated FVII or activated prothro
Autor:
Srilatha D Tangada, Eva-Maria Muchitsch, Gerald Schrenk, Borislava G. Pavlova, Werner Höllriegl, Frank M. Horling, Peter Turecek, Artur Mitterer, Hanspeter Rottensteiner, Brigitt Abbühl, Herbert Gritsch, Barbara Dietrich, Alexandra Schiviz, Birgit M. Reipert, Miranda Chapman, Friedrich Scheiflinger
Publikováno v:
Expert Review of Clinical Pharmacology. 8:163-177
Nonacog gamma is a new recombinant factor IX to treat factor IX deficiency. It is indicated for control of bleeding episodes, perioperative management and routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and child
Autor:
Jeff McKee, Andreas Goppelt, Alexander Bauer, Kevin M. Lewis, Martin J. Wolfsegger, Alexandra Schiviz
Publikováno v:
ISRN Surgery
Blood loss during hepatic surgery leads to poor patient outcomes. This study investigates the hemostatic efficacy of a novel sealing hemostatic pad (polyethylene glycol-coated collagen, PCC) and a fibrin sealant pad (fibrin-thrombin coated collagen,